Skip to main navigation Skip to search Skip to main content

Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.

  • Barbara Guinn
  • , Garrett Casey
  • , Sara A. Collins
  • , Tim O'Brien
  • , M. Yvonne Alexander
  • , Mark Tangney

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland on May 15 and 16, 2008 (http://crr.ucc.ie/isgct/). The meeting was jointly organized with the British Society for Gene Therapy and the International Society for Cell and Gene Therapy of Cancer. Because of the location of the conference and the co-organization of this meeting with the British and International Gene Therapy societies, the meeting enjoyed a range of talks from some of the major leaders in the field. Particularly notable were the talented molecular and cell biologists from Ireland who have contributed cutting edge science to the field of gene therapy. Topics including cardiovascular disease, repair of single-gene disorders, and cancer gene therapy were discussed with presentations ranging from basic research to translation into the clinic. Here we describe some of the most exciting presentations and their potential impact on imminent clinical gene therapy trials.
    Original languageEnglish
    Pages (from-to)967-978
    JournalHuman Gene Therapy
    Volume19
    Issue number10
    DOIs
    Publication statusPublished - 1 Oct 2008

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • gene and cell therapy

    Fingerprint

    Dive into the research topics of 'Tripartite meeting in gene and cell therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer.'. Together they form a unique fingerprint.

    Cite this